Goal
Combat aging and extend healthy lifespan by increasing cellular NAD levels and activating sirtuin pathways.
Problem
Age-related decline and the difficulty of proving anti-aging effects in humans.
Concept Summary
The product is an over-the-counter nutraceutical pill that delivers nicotinamide riboside (a NAD precursor) and pterostilbene (a sirtuin-activating antioxidant). By raising intracellular NAD, the formulation aims to mimic the metabolic effects of caloric restriction, thereby activating SIRT1 and related pathways that have been shown in animal models to extend lifespan.
Detailed Description
Basis contains two active ingredients: (1) nicotinamide riboside, which cells convert to NAD^+, a coenzyme required for sirtuin deacetylase activity; and (2) pterostilbene, a plant-derived antioxidant that may stimulate sirtuins via a distinct mechanism. The company claims the combination produces a synergistic effect, improving cellular metabolism, energy production, and potentially slowing age-related functional decline. The supplement is marketed without FDA drug approval, relying on the regulatory pathway for dietary supplements. No formal clinical trials are reported; the evidence cited consists of pre-clinical animal studies and anecdotal user feedback.
Principles
- NAD precursor supplementation
- Sirtuin activation
- Caloric-restriction mimetic effect
Scientific Domains
Materials
- Nicotinamide riboside
- Pterostilbene
Mechanisms of Action
- Increase intracellular NAD^+ levels
- Activate SIRT1 deacetylase activity
- Enhance mitochondrial function and metabolic efficiency
Applications
- Anti-aging dietary supplement
- Potential metabolic health aid
Claimed Performance
The pill is marketed as a means to keep users "young", improve energy levels, and extend healthy lifespan; the company cites animal studies where NAD precursors increased lifespan in mice and worms.
Experimental Evidence
The article mentions pre-clinical studies showing NAD precursors extend lifespan in mice and worms, and anecdotal feedback from users reporting increased energy and well-being. No peer-reviewed human clinical data are presented.
Replication Status
No independent replication of human efficacy is reported.
Limitations
- Lack of rigorous human clinical trial data
- Regulatory classification as a supplement limits health claims
- Potential placebo effect in anecdotal reports
Red Flags
- Claims of anti-aging benefits without FDA-approved clinical evidence
- Reliance on anecdotal user feedback
- Potential for overstated efficacy
